Der DOW JONES verliert heute 40,55 Zähler oder 0,50% auf 8000,60 Punkte
Die Hightechs des Nasdaq Composite verlieren 12,21 Zähler oder 0,91% auf 1334,33 Punkte.
Meistgehandelte Aktie
Der NASDAQ 100 verliert 9,03 Zähler oder 0,89% auf 1005,88Punkte
schwächer zeigte sich der Amex Interactiv Internet Index (IIX) , er verliert aktuell 0,68 Zähler bzw 0,80 Prozent auf 84,20 Punkte .
Der PHLX Semiconductor Sector (SOX) verliert 2,64 Zähler oder 0,91% auf 288,99Punkte
Der Amex Biotech Index (BTK) verliert 2,50 Zähler bzw. 0,76% auf 324,34Punkte
Der S&P 500 (SPX) verliert 6,04 Zähler oder 0,71% auf 845,13Punkte
***
EU/$ >> 1,074 ***
AFTER THE CLOSE
ADC Telecom tops estimates; updates guidance (ADCT) 51.70 -0.03: Reports Q1 (Jan) loss of $0.03 per share,
$0.01 betterthan the Multex consensus of ($0.04); revenues fell 31.9% year/year to $199.9 mln vs the $199.4 mln consensus; company backs FY03 earnings guidance of "about $1.50" -- Multex consensus estimate is for earnings of $1.53 per share.
Exelixis tops estimates (EXEL) 5.50 -0.11: Reports Q4 (Dec) loss of $0.34 per share,
$0.07 better than the Multex consensus of ($0.41); revenues fell 2.3% year/year to $12.5 mln vs the $12.1 mln consensus; at December 31, 2002, cash, cash equivalents, short-term investments and restricted cash totaled approximately $222.0 million -- anticipates that revenues will increase in the range of 30 to 40% from 2002.
L-3 Comms reaffirms guidance (LLL) 38.25 +0.90: Reaffirms its goal of 20% annual growth for sales and earnings, including 8-10% growth excluding acquisitions, in 2003; says its assumptions for $175 mln in sales of explosive detection systems (EDS) in 2003 remain unchanged.
Cephalon beats Q4 consensus; sees Q1 lower (CEPH) 51.70 -0.03: Reports Q4 (Dec) earnings of $0.41 per share, ex-items,
$0.05 better than the Multex consensus of $0.36; revenues rose 92.7% year/year to $144.3 mln vs the $142.2 mln consensus; sees Q1 EPS of $0.20 vs Multex consensus of $0.32.
Agile Software tops estimates (AGIL) 6.83 -0.16: Reports Q3 (Jan) loss of $0.07 per share,
$0.06 better than the Multex consensus of ($0.13); revenues rose 2.3% year/year to $17.9 mln vs the $16.5 mln consensus.
Synopsys tops Q1 estimates; updates Q2 guidance (SNPS) 39.75 +0.19: Reports Q1 (Jan) earnings of $0.68 per share, ex-items,
$0.04 better than the Multex consensus of $0.64; revenues rose 52.8% year/year to $268.1 mln vs the $266.4 mln consensus; sees Q2 EPS of $0.67-$0.72 vs Multex consensus $0.72.
CV Therapeutics beats by 3 cents (CVTX) 16.90 +0.10: Reports Q4 (Dec) loss of $1.09 per share,
$0.03 better than the Multex consensus of ($1.12); revenues rose 65.4% year/year to $1.8 mln vs the $1.1 mln consensus.
THQ Inc tops estimates (THQI) 13.35 +0.02: Reports Q4 (Dec) earnings of $0.41 per share,
$0.01 better than the Multex consensus of $0.40; revenues rose 10.9% year/year to $217.8 mln vs the $216.1 mln consensus
weitere unter nachbörsliche quartalsberichte
----------------------------------
Nachbörsliche WINNER+LOSER:
Regulärer Handel +After Hours- Top 100
____________________________________________
Nasdaq 100 Future
Nasdaq 100 After Hours Indicator

_____________________________________________
_____________________________________________
KURSLISTE in €
DAX ------------------------------
NEMAX 50

DOW JONES 30 ------------
NASDAQ 100
US-STOCKS -------------------
MDAX

--------------------------------------------------------------
NACHBÖRSLICHE QUARTALSBERICHTE
EARNINGS KALENDER
WIRTSCHAFTSDATEN -VORSCHAU
FED- KALENDER
UP- and DOWNGRADES